Retatrutide purity was outstanding
Running metabolic assays with Retatrutide. Lot had >99% purity by reverse-phase HPLC — above spec. Mass spec confirmed molecular weight. Best peptide supplier we've worked with.
Tesamorelin is a stabilised GHRH analogue with demonstrated efficacy in HIV-associated lipodystrophy clinical trials. It stimulates endogenous GH secretion and is studied in visceral adiposity and metabolic research.
| Format | Lyophilized Vial |
|---|---|
| Dosage | 5mg |
| Purity | >98% |
| Sub-Line | APEX |
In Stock — Overnight and 2–3 day delivery available
Tesamorelin is a synthetic analogue of GHRH in which a trans-3-hexenoic acid group is conjugated to the N-terminus to enhance metabolic stability. It is FDA-approved as Egrifta® for HIV-associated lipodystrophy, providing a robust clinical data foundation for further research.
Tesamorelin is studied in visceral adiposity, metabolic syndrome, cognitive function (IGF-1 CNS effects), and GH deficiency research. Clinical trial data from the EGRIFTA program provides an unusually strong evidence base.
For Research Use Only. Rainbow Peptide supplies Tesamorelin exclusively for in vitro and laboratory research purposes. Not for human or veterinary use.
Third-Party Verified
We don't just claim purity — we prove it. Every batch of Tesamorelin is independently tested by an accredited third-party laboratory before it reaches you. Your COA is linked to your specific lot number.
Verified purchases from active research labs and scientists
Running metabolic assays with Retatrutide. Lot had >99% purity by reverse-phase HPLC — above spec. Mass spec confirmed molecular weight. Best peptide supplier we've worked with.
Internal verification confirmed COA data. Purity was 98.6% HPLC. Peptide behavior in our assay was consistent with published data. Will order again for next study phase.
AOD-9604 arrived quickly and in excellent condition. Cold pack preserved temperature. COA was thorough. Results in metabolic assays consistent with expected parameters.